Abstract:Background: Since the COVID-19 pandemic, many studies have reported severe neurologic effects of the infection on the brain. Intracerebral hemorrhage (ICH) is a particular pathology that can result in these devastating neurologic effects. Objectives: The primary aim of our study is to investigate the possible difference in the clinical and laboratory characteristics of ICH between patients with positive COVID-19 tests and those with negative tests. The potential effect of this difference on the prognosis of the patients during their stay in the intensive care unit (ICU) is a secondary aim of the study. Methods: In this retrospective cohort review, our data were collected from the electronic medical database of the Benghazi Medical Center (BMC) for the period from January 2021 to June 2022. We depended mainly on the admission paper information documented by emergency doctors, and mortality was measured depending on the clinical status after discharge from the ICU. Results: This study included a sample of 72 patients, 34 patients (47.2%) were considered COVID-19 positive, and 38 patients (52.8%) were COVID-19 negative. The difference between groups was significant in ICH score ≥3 (higher in positive patients), INR (lower in positive patients), the incidence of new-onset hypertension (higher in positive patients), location of hematoma (infratentorial in positive patients), and intraventricular hemorrhage (IVH) extension (more in positive patients). Also, COVID-19 was significantly associated with ICH score ≥3 (OR 4.6, 95% CI 1.2 - 18.6, p = 0.03, R2 = 0.16), INR (𝛃 = 0.35, 95% CI 0.09 - 0.62, p < 0.003, R2 = 0.136), risk of ventilation (OR 14.1, 95% CI 3.5 - 56.9, p < 0.001, R2 = 0.26), hydrocephalus (OR 9.41, 95% CI 2.72 - 32.5, p = 0.001, R2 = 0.19), infratentorial location (OR 3.7, 95% CI 1.1 - 12.5, p = 0.04, R2 = 0.14), IVH extension (OR 3.5, 95% CI 1.2 - 10.4, p = 0.03, R2 = 0.09), new-onset hypertension (OR 4.2, 95% CI 1.5 - 11.9, p = 0.007, R2 = 0.10), and mortality (OR 4.9, 95% CI 1.6 - 15.3, p = 0.04, R2 = 0.15). The difference in survivability between groups was statistically insignificant (X2 = 0.41, log-rank, P = 0.53). Conclusion: The current study demonstrates, with sufficient evidence, that COVID-19 infection causes a significant change in some critical baseline characteristics like INR values, location, and IVH extension that influence the prognosis of ICH in ICU patients.

Correction: Suspected intracranial hypertension in COVID-19 patients with severe respiratory failure

Erratum: The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension (Ann Transl Med (2020) 8: 430 DOI: 10.21037/atm.2020.03.229)

Erratum to: Transmission risk of patients with COVID-19 meeting discharge criteria should be interpreted with caution (Journal of Zhejiang University-SCIENCE B, (2020), 21, 5, (408-410), 10.1631/jzus.B2000117)

Correction to: Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis

Erratum To: Transmission Risk of Patients with COVID-19 Meeting Discharge Criteria Should Be Interpreted with Caution

Correction: Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

Erratum to "A case of spontaneous intracranial hypotension in a 45-year-old male with headache, behavior changes and altered mental status" [Radiology Case Reports 17 (2022) 2289-2294]

Erratum: Effects of awake prone position vs. usual care on acute hypoxemic respiratory failure in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study

Corrigendum: Assessment of risk scores to predict mortality of COVID-19 patients admitted to the intensive care unit

Clinical Characteristics and Mortality of Intensive Care Patients With Intracerebral Hemorrhage and COVID-19: A Retrospective Cohort Analysis

Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension

Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19

COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled Analysis

Correction: Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients

Correction: Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City

Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study

Corrigendum: Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19

Autonomic Function and Baroreflex Control in COVID-19 Patients Admitted to the Intensive Care Unit

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

Correction To: “optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke ( SELECT ): A Prospective Multicenter Cohort Study of Imaging Selection”